<DOC>
	<DOC>NCT01750242</DOC>
	<brief_summary>To evaluate DBS device settings and match with the features of the DBS care management software.</brief_summary>
	<brief_title>Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study</brief_title>
	<detailed_description>This is a study done on Parkinson disease subjects who have received the DBS system implanted in their subthalamic nucleus.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patient with Medtronic Deep Brain Stimulation therapy for idiopathic levodopa responsive Parkinson's Disease Patient who has had lead placement in the Subthalamic nucleus Patient with preop MRI available Patient with postop CT scan available showing placement of the lead Patient who has documented improvement of at least 35% on UPDRS III scores from baseline preoperative off medication state compared to post DBS implant stimulation on/medications off Patient who has had clinically significant persistent stimulation related adverse effects Patient who has evidence of lead migration without lead revision Patient with other brain malformations that would make it difficult to process images (ablative surgery in the basal ganglia, resective surgery, brain tumor)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>